AI Tokens
Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

Common-Size Income Statement
Quarterly Data

Elevance Health Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Premiums 82.68 82.85 82.89 82.52 83.44 83.51 83.84 80.56 82.31 81.94 84.44 82.77 83.00 84.35 85.61 84.82 85.10 85.95 86.54 85.43 85.50 85.74 86.22
Product revenue 12.80 12.57 12.58 13.10 12.30 12.23 11.91 14.92 13.16 12.79 10.64 12.71 12.19 11.20 9.60 10.43 10.02 9.27 8.71 9.79 9.43 9.14 8.53
Service fees 4.52 4.58 4.54 4.38 4.27 4.27 4.24 4.51 4.52 5.27 4.92 4.53 4.81 4.45 4.79 4.75 4.87 4.78 4.75 4.79 5.06 5.12 5.25
Operating revenue 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Benefit expense -74.90 -74.31 -71.96 -77.19 -76.15 -74.27 -72.41 -74.46 -73.68 -70.73 -72.26 -73.81 -72.05 -72.86 -73.48 -75.86 -74.21 -74.78 -74.47 -76.46 -74.95 -74.41 -73.83
Cost of products sold -11.18 -11.02 -11.04 -11.20 -10.74 -10.71 -10.22 -13.36 -11.39 -11.15 -9.05 -11.39 -10.94 -9.98 -8.31 -9.19 -8.67 -7.98 -7.61 -8.52 -8.15 -7.85 -7.21
Cost of operating revenue -86.08% -85.33% -83.00% -88.39% -86.89% -84.98% -82.63% -87.83% -85.07% -81.88% -81.31% -85.20% -82.99% -82.83% -81.79% -85.05% -82.88% -82.76% -82.08% -84.98% -83.11% -82.27% -81.04%
Gross profit 13.92% 14.67% 17.00% 11.61% 13.11% 15.02% 17.37% 12.17% 14.93% 18.12% 18.69% 14.80% 17.01% 17.17% 18.21% 14.95% 17.12% 17.24% 17.92% 15.02% 16.89% 17.73% 18.96%
Operating expense -11.40 -11.13 -12.79 -10.98 -10.53 -10.11 -10.87 -10.68 -11.78 -11.72 -11.56 -11.78 -12.88 -11.11 -11.46 -11.50 -11.39 -11.09 -11.46 -11.72 -11.10 -11.48 -12.23
Amortization of other intangible assets -0.21 -0.22 -0.23 -0.33 -0.32 -0.30 -0.32 -0.40 -0.27 -0.37 -0.27 -0.51 -0.50 -0.51 -0.56 -0.62 -0.57 -0.43 -0.34 -0.37 -0.38 -0.27 -0.25
Operating income 2.31% 3.32% 3.99% 0.29% 2.26% 4.61% 6.18% 1.10% 2.88% 6.02% 6.86% 2.51% 3.63% 5.55% 6.20% 2.83% 5.16% 5.72% 6.12% 2.92% 5.41% 5.98% 6.48%
Net investment income 2.06 1.41 1.55 1.00 1.25 0.98 1.21 1.17 1.23 1.18 1.10 1.25 1.16 0.96 0.92 0.94 0.94 0.99 0.95 0.98 0.94 1.20 0.91
Net gains (losses) on financial instruments -0.10 -0.11 -0.16 -0.12 0.00 -0.27 -0.95 -0.16 -0.28 -0.20 -0.38 -0.79 -0.29 -0.28 -0.27 -0.28 -0.14 -0.60 -0.40 0.59 -0.17 0.52 -0.01
Gain (loss) on sale of business 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest expense -0.71 -0.73 -0.72 -0.74 -0.70 -0.69 -0.71 -0.76 -0.67 -0.65 -0.63 -0.61 -0.61 -0.60 -0.60 -0.58 -0.54 -0.54 -0.53 -0.56 -0.57 -0.62 -0.60
Loss on extinguishment of debt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 -0.02 0.00
Income before income tax expense 3.56% 3.89% 4.66% 0.44% 2.81% 4.64% 5.74% 1.35% 3.07% 6.91% 6.95% 2.36% 3.89% 5.63% 6.25% 2.91% 5.42% 5.57% 6.14% 3.89% 5.61% 7.07% 6.78%
Income tax expense -0.89 -0.97 -1.10 0.67 -0.44 -1.11 -1.26 -0.43 -0.82 -1.58 -1.63 -0.40 -0.83 -1.35 -1.47 -0.49 -1.35 -1.28 -1.40 -0.76 -1.39 -1.66 -1.59
Net income 2.66% 2.92% 3.56% 1.11% 2.37% 3.53% 4.48% 0.92% 2.25% 5.32% 5.32% 1.96% 3.06% 4.28% 4.78% 2.42% 4.07% 4.29% 4.74% 3.12% 4.23% 5.41% 5.19%
Net (gain) loss attributable to noncontrolling interests 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.01 0.02 0.00 -0.01 0.06 -0.03 -0.01 -0.04 -0.03 0.01 0.01 0.03 0.03 0.02 -0.02 -0.01
Shareholders’ net income 2.71% 2.94% 3.56% 1.11% 2.37% 3.53% 4.48% 0.93% 2.27% 5.32% 5.31% 2.02% 3.03% 4.27% 4.75% 2.39% 4.08% 4.30% 4.76% 3.16% 4.24% 5.39% 5.19%

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


A comprehensive analysis of the common-size income statement reveals a strategic shift in revenue composition and a general compression of profit margins over the analyzed period. There is a clear transition in the revenue mix, characterized by a reduction in the reliance on premiums and an increase in product-related revenue.

Revenue Mix and Diversification
Premiums, the primary revenue driver, exhibit a long-term downward trend, decreasing from 86.22% of operating revenue in March 2021 to 82.68% by September 2026. Conversely, product revenue has grown significantly, rising from 8.53% to 12.80% over the same period. Service fees have remained relatively stable, though a slight contraction is noted, moving from 5.25% to 4.52%.
Direct Cost Analysis
The cost of operating revenue has experienced a general increase, rising from 81.04% to 86.08%. This trend is driven by both benefit expenses and the cost of products sold. Benefit expenses fluctuate between 70% and 77%, with peaks occurring in late 2021, late 2022, and late 2025. The cost of products sold has increased in tandem with product revenue, moving from 7.21% to 11.18%, suggesting that while product revenue is growing, the associated costs are scaling proportionally.
Gross and Operating Profitability
Gross profit margins have declined from a peak of 18.96% in March 2021 to 13.92% in September 2026. Operating expenses have remained remarkably consistent, generally fluctuating between 10% and 12% of operating revenue. Consequently, the compression in gross profit has led to significant volatility in operating income. Operating income margins dropped from 6.48% in early 2021 to a low of 0.29% in December 2025, before recovering slightly to 2.31% by September 2026.
Net Income and Non-Operating Performance
Net investment income has provided a steady and slightly increasing contribution, rising from 0.91% to 2.06%. Interest expenses have remained stable but trended slightly upward from 0.60% to 0.71%. Despite the support from investment income, shareholders' net income has followed the downward trajectory of operating income, declining from a peak of 5.39% in June 2021 to 2.71% by September 2026.

The overall financial trajectory indicates that while the organization is successfully diversifying its revenue streams through product growth, it is facing intensifying pressure on its direct costs. The resulting margin compression has led to a decrease in overall net profitability, although the growth in net investment income serves as a partial buffer against the decline in operating margins.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?